AYTU BIOPHARMA, INC Annual Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
Aytu Biopharma, Inc annual/quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from 2019 to 2024.
  • Aytu Biopharma, Inc Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending September 30, 2023 was $1.36M, a 141% increase year-over-year.
  • Aytu Biopharma, Inc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $4.04M, a 5.96% increase from 2023.
  • Aytu Biopharma, Inc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $3.81M, a 21.1% increase from 2022.
  • Aytu Biopharma, Inc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $3.15M, a 152% increase from 2021.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.04M +$227K +5.96% Jul 1, 2023 Jun 30, 2024 10-K 2024-09-26
2023 $3.81M +$664K +21.1% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-26
2022 $3.15M +$1.9M +152% Jul 1, 2021 Jun 30, 2022 10-K 2023-10-12
2021 $1.25M +$209K +20.1% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-27
2020 $1.04M +$1.04M Jul 1, 2019 Jun 30, 2020 10-K 2021-09-28
2019 $0 Jul 1, 2018 Jun 30, 2019 10-K 2020-10-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.